ketoconazole has been researched along with dutasteride in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Avram, MR; Rogers, NE | 1 |
| Balk, SP; Kantoff, PW; Nakabayashi, M; Oh, WK; Ross, RW; Sartor, O; Taplin, ME | 1 |
| Balk, SP; Beer, TM; Bubley, GJ; Denmeade, SR; Duggan, SE; Kantoff, PW; Ko, YJ; Mantzoros, CS; Mathew, P; Oh, WK; Regan, MM; Rittmaster, R; Ryan, CW; Sartor, O; Taplin, ME; Tu, SM; Werner, L | 1 |
| Balk, S; Ellis, W; Gulati, R; Hunter Merrill, R; Kantoff, P; Lange, P; Lin, DW; Marck, B; Matsumoto, AM; Montgomery, B; Mostaghel, EA; Nelson, PS; Penning, T; Tamae, D; Taplin, ME; True, LD; Vessella, R | 1 |
| Balk, SP; Bubley, GJ; Cai, C; Chen, EJ; Gao, S; Kantoff, PW; Lis, RL; Loda, M; Montgomery, RB; Nelson, PS; Schaefer, R; Sowalsky, AG; Taplin, ME; Troncoso, P; True, LD; Voznesensky, O; Ye, H | 1 |
| Ioannides, D; Lazaridou, E | 1 |
| Cai, C; de Waal, E; Gao, S; Han, D; Han, W; Macoska, JA; Owiredu, J; Valencia, K | 1 |
3 review(s) available for ketoconazole and dutasteride
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical treatments for male and female pattern hair loss.
Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin | 2008 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
2 trial(s) available for ketoconazole and dutasteride
| Article | Year |
|---|---|
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Azasteroids; Cholestenone 5 alpha-Reductase; Dutasteride; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Treatment Outcome | 2009 |
Targeted androgen pathway suppression in localized prostate cancer: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgen Antagonists; Androgen Receptor Antagonists; Androsterone; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Azasteroids; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dihydrotestosterone; Dutasteride; Goserelin; Humans; Ketoconazole; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Pilot Projects; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Steroid 17-alpha-Hydroxylase; Testosterone; Tosyl Compounds; Treatment Outcome | 2014 |
4 other study(ies) available for ketoconazole and dutasteride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Azasteroids; Biomarkers, Tumor; Disease Progression; Dutasteride; Humans; Ketoconazole; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 2009 |
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.
Topics: Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA Helicases; DNA-Binding Proteins; Drug Resistance, Neoplasm; Dutasteride; Humans; Ketoconazole; Leuprolide; Male; Middle Aged; Mutation; Progesterone; Prostatic Neoplasms, Castration-Resistant; PTEN Phosphohydrolase; Receptors, Androgen; Steroid 17-alpha-Hydroxylase | 2015 |
A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chlorocebus aethiops; Chromatin; Codon, Nonsense; COS Cells; Cytochrome P-450 Enzyme Inhibitors; Drug Resistance, Neoplasm; Dutasteride; Gene Expression Regulation, Neoplastic; Humans; Ketoconazole; Male; p300-CBP Transcription Factors; Prostatic Neoplasms, Castration-Resistant; Protein Binding; Receptors, Androgen; Signal Transduction; Steroid 17-alpha-Hydroxylase; Time Factors; Transcription, Genetic; Transfection; Treatment Outcome | 2017 |